KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Shares Outstanding (2019 - 2025)

Clover Health Investments' Shares Outstanding history spans 7 years, with the latest figure at $426.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 2.94% year-over-year to $426.7 million; the TTM value through Dec 2025 reached $426.7 million, up 2.94%, while the annual FY2025 figure was $426.7 million, 2.94% up from the prior year.
  • Shares Outstanding reached $426.7 million in Q4 2025 per CLOV's latest filing, up from $421.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $473.3 million in Q1 2022 to a low of $87.9 million in Q4 2023.
  • Average Shares Outstanding over 5 years is $338.2 million, with a median of $395.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: soared 4572.92% in 2023, then plummeted 77.71% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $352.6 million in 2021, then increased by 8.89% to $384.0 million in 2022, then crashed by 77.12% to $87.9 million in 2023, then skyrocketed by 371.72% to $414.5 million in 2024, then rose by 2.94% to $426.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Shares Outstanding are $426.7 million (Q4 2025), $92.4 million (Q3 2025), and $418.4 million (Q2 2025).